Pyrazole derivatives as s1p1 agonists

作者: Nuria Aguilar Izquierdo , Marta Carrascal Riera , Montserrat Erra Sola , Bernat Vidal Juan , Lorena Taboada Martinez

DOI:

关键词:

摘要: The present invention relates to a compound of formula (I), the process for preparing such compounds and their use in treatment pathological condition or disease susceptible amelioration by sphingosine-1-phosphate receptors (S1P1) agonists.

参考文章(19)
Christian Schnell, Peter C. Hiestand, S1P receptor modulators for treating multiple sclerosis ,(2007)
Timothy L. Macdonald, Kevin R. Lynch, Method for treatment of neuropathic pain ,(2007)
Andre Narodylo, Wolfgang Gottenauer, Anne H. de Boer, Joachim Goede, Coenraad Lerk, Pharmaceutical powder cartridge with integrated metering device and inhaler for powdered medicaments ,(1996)
Henderik Willem Frijlink, Doetie Gjaltema, Paul Hagedoorn, Anne Haaije De Boer, Joachim Goede, Powder formulation disintegrating system and method for dry powder ,(2002)
Gilles Feutren, Robert Paul Hof, Volker Brinkmann, Use of S1P Receptor Agonists in Heart Diseases ,(2003)
Karl-Heinz Thierauch, Ellalahewage Sathyajith Kumarasinghe, Philip Wickens, Holger Hess-Stumpp, Peter Ellinghaus, Manoj Patel, Michael Härter, Stephen Boyer, Ajay Kumar Bhargava, Patrick Paulus, Hartmut Beck, Susanne Greschat, Inhibitors of hypoxia inducible factor (hif) useful for treating hyper-proliferative disorders and diseases associated with angiogenesis ,(2008)
Betty C. Soliven, Treatment of inflammatory diseases ,(2007)